No one likes a long line. But privileging the rich and powerful – as has often been the case – may undermine trust in the vaccine rollout.
L’expertise universitaire, l’exigence journalistique
Articles sur COVID-19
Affichage de 3121 à 3140 de 7938 articles
Plus a round-up of the coronavirus situation around the world marking one year since COVID-19 was declared a pandemic. Listen to Episode 6 of The Conversation Weekly.
Review of the latest evidence identifies the risk factors for pregnant women.
COVID-19 has diverted international attention and resources away from peacebuilding. This increases the risk of global insecurity and instability.
Four articles from The Conversation US archive provide context and analysis on the historic legislation.
Rolling out vaccines, sticking with public health measures, and keeping misinformation and complacency in check. These are just some of what to expect as the pandemic enters its second year.
From some statistics 2020 looks like economic good times. Have relief measures averted economic pain or simply deferred it?
It is morally unjustifiable for tech companies to walk away from the pandemic with massive profits while schools are burdened with debt.
Confusion reigns about Nigeria’s distribution plan for its first batch of COVID-19 vaccines.
The lead role of public health researchers continues to be important. But there is growing acknowledgement that social scientists have to be present from the very beginning.
Lockdowns didn’t have the impact many had hoped.
A psychologist explains why certain goals may be more effective than others in breaking screen habits.
China is providing masks, vaccines, medical equipment and personnel to African countries ignored by the U.S. in recent years, positioning itself as an essential partner to the region.
Why South Korea and Ghana have fared better than the UK, Brazil and India.
The cognitive effort of managing the conflicting messages of a working through a pandemic is tiring us out.
The babies born since March 11 2020 have faced a unique set of challenges.
Public health measures have helped control COVID-19 in Australia. But they’ve affected other winter viruses, too.
With four COVID-19 vaccines approved for use in Canada, it’s time to answer FAQs about efficacy, immunity, eradication and variants.
COVID-19 prevention measures are at odds with guidelines for healthy development of children’s immune systems. The result may be a cluster of youth with more allergies, asthma and autoimmune disease.
Cross-partisanship co-operation among political leaders doesn’t neatly translate into a similar consensus among the Canadian public, including those with disabilities or chronic health conditions.
Les contributeurs les plus fréquents
-
Professorial Fellow, University of Canberra
-
Associate Professor, Epidemiology, Deakin University
-
Professor of Economics, UNSW Sydney
-
Chair in Epidemiology, Deakin University
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Professor of Biostatistics and Epidemiology, University of South Australia
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Visiting Fellow, Crawford School of Public Policy, Australian National University
-
Senior Research Fellow in Global Health, University of Southampton
-
Professor of Medicine, University of East Anglia
-
Associate professor, UNSW Sydney
-
Professor of Medicine, University of Virginia
-
Professor of Public Health, University of Sheffield
-
Associate Professor of Bioethics, University of Portsmouth
